Functional analysis reveals that RBM10 mutations contribute to lung adenocarcinoma pathogenesis by deregulating...

Area of Science:

• Molecular Biology
• Cancer Genetics
• RNA Biology

Background:

• RNA splicing factor RBM10 is frequently mutated in lung adenocarcinoma (LUAD).
• The functional impact of RBM10 mutations in LUAD remains poorly understood.
• RBM10 is proposed as a cancer gene, but its precise role in LUAD pathogenesis requires elucidation.

Purpose of the Study:

• To investigate the functional consequences of RBM10 mutations in LUAD.
• To determine how RBM10 mutations affect its RNA splicing regulatory functions.
• To explore the link between RBM10 mutations, RNA splicing alterations, and LUAD cell proliferation.

Main Methods:

• Integrative analysis of RBM10 mutation and RNA expression data from LUAD patients.
• Development of an experimental pipeline to assess the functional effects of RBM10 mutations.
• Functional characterization of six representative LUAD-associated RBM10 mutations, including nonsense, frameshift, and missense variants.

Main Results:

• LUAD-associated RBM10 mutations show a mutational spectrum similar to tumor suppressors.
• RBM10 mutations in LUAD patients lacking canonical oncogenes correlate with reduced RBM10 expression.
• Nonsense and frameshift RBM10 mutations caused loss-of-function, while missense mutations differentially impacted RNA splicing.
• RBM10 missense mutants altered RNA splicing of target genes, correlating with changes in LUAD cell proliferation.

Conclusions:

• RBM10 mutations contribute to LUAD pathogenesis primarily through deregulation of RNA splicing.
• Altered RBM10 splicing activity impacts LUAD cell proliferation.
• The developed methods can be applied to study other cancer-associated RNA splicing regulators.